Prolonged response after the discontinuation of nivolumab after resistance to gefitinib. [electronic resource]
- The clinical respiratory journal Oct 2019
- 657-658 p. digital
Publication Type: Case Reports; Letter
1752-699X
10.1111/crj.13065 doi
Adenocarcinoma of Lung--diagnostic imaging Adrenal Insufficiency--chemically induced Aged Antineoplastic Agents, Immunological--administration & dosage Central Nervous System Neoplasms--secondary Gefitinib--therapeutic use Genes, erbB-1--genetics Humans Lung Neoplasms--diagnostic imaging Male Mutation Nivolumab--administration & dosage Protein Kinase Inhibitors--therapeutic use Treatment Outcome Withholding Treatment